Hamburg and Heidenheim will go head-to-head for the third time this season on matchday 21. The newly-promoted team beat the ...
Bayern Munich were looking to get back on track in the Bundesliga after losing their first game of the season last weekend ...
Herpes is one of the most common viral infections in the world, yet it remains widely misunderstood. Caused by the herpes ...
Investigational antiviral pritelivir demonstrates efficacy and improved tolerability over current treatments for refractory HSV in high-risk patients.
Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with standard-of-care ...
For the highly talented defender, this is the next logical step in a development that has been carefully planned at Volkspark ...
Last Saturday evening, HSV hosted FC Bayern Munich for the top match. In March, they will play twice at the exclusive kickoff ...
Clinical Trials Arena on MSN
AiCuris reports positive Phase III pritelivir results for HSV patients
The trial enrolled and treated 101 immunocompromised patients with refractory or resistant HSV infection.
Full abstracts will be released on February 4, 2026, at 7:00 am CET/1:00 am EST and will be available via the conference website here .
HSV against Bayern. Before the match, many thought the only question was how big the win for FCB would be. But things turned ...
Innovative Molecules GmbH, a German clinical stage biotech company focused on development of novel agents in the field of ...
Hamburg have officially confirmed Emir Sahiti’s reported on loan out to Maccabi Tel Aviv. Two more HSV arrivals are set to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results